Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]

Detalles Bibliográficos
Autores principales: Sun, Zhiwei, Zhou, Shixia, Tang, Junling, Ye, Ting, Li, Jingyuan, Liu, Doudou, Zhou, Jian, Wang, Jianyu, Xing, H. Rosie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350453/
https://www.ncbi.nlm.nih.gov/pubmed/34364168
http://dx.doi.org/10.1016/j.ebiom.2021.103508
_version_ 1783735764424589312
author Sun, Zhiwei
Zhou, Shixia
Tang, Junling
Ye, Ting
Li, Jingyuan
Liu, Doudou
Zhou, Jian
Wang, Jianyu
Xing, H. Rosie
author_facet Sun, Zhiwei
Zhou, Shixia
Tang, Junling
Ye, Ting
Li, Jingyuan
Liu, Doudou
Zhou, Jian
Wang, Jianyu
Xing, H. Rosie
author_sort Sun, Zhiwei
collection PubMed
description
format Online
Article
Text
id pubmed-8350453
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83504532021-08-15 Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55] Sun, Zhiwei Zhou, Shixia Tang, Junling Ye, Ting Li, Jingyuan Liu, Doudou Zhou, Jian Wang, Jianyu Xing, H. Rosie EBioMedicine Corrigendum Elsevier 2021-08-04 /pmc/articles/PMC8350453/ /pubmed/34364168 http://dx.doi.org/10.1016/j.ebiom.2021.103508 Text en © 2018 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Sun, Zhiwei
Zhou, Shixia
Tang, Junling
Ye, Ting
Li, Jingyuan
Liu, Doudou
Zhou, Jian
Wang, Jianyu
Xing, H. Rosie
Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title_full Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title_fullStr Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title_full_unstemmed Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title_short Corrigendum to “Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression” [EBioMedicine 37 (2018) 47–55]
title_sort corrigendum to “sec23a mediates mir-200c augmented oligometastatic to polymetastatic progression” [ebiomedicine 37 (2018) 47–55]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350453/
https://www.ncbi.nlm.nih.gov/pubmed/34364168
http://dx.doi.org/10.1016/j.ebiom.2021.103508
work_keys_str_mv AT sunzhiwei corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT zhoushixia corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT tangjunling corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT yeting corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT lijingyuan corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT liudoudou corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT zhoujian corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT wangjianyu corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755
AT xinghrosie corrigendumtosec23amediatesmir200caugmentedoligometastatictopolymetastaticprogressionebiomedicine3720184755

Ejemplares similares